↓ Skip to main content

Cochrane Database of Systematic Reviews

Yellow fever vaccine for patients with HIV infection

Overview of attention for article published in this source, January 2014
Altmetric Badge

Mentioned by

2 tweeters
1 Wikipedia page


28 Dimensions

Readers on

165 Mendeley
Yellow fever vaccine for patients with HIV infection
Published by
John Wiley & Sons, Ltd, January 2014
DOI 10.1002/14651858.cd010929.pub2
Pubmed ID

Barte, Hilary, Horvath, Tara H, Rutherford, George W


Yellow fever (YF) is an acute viral haemorrhagic disease prevalent in tropical Africa and Latin America. The World Health Organization (WHO) estimates that there are 200,000 cases of YF and 30,000 deaths worldwide annually. Treatment for YF is supportive, but a live attenuated virus vaccine is effective for preventing infection. WHO recommends immunisation for all individuals > 9 months living in countries or areas at risk. However, the United States Advisory Committee on Immunization Practices (ACIP) advises that YF vaccine is contraindicated in individuals with HIV. Given the large populations of HIV-infected individuals living in tropical areas where YF is endemic, YF vaccine may be an important intervention for preventing YF in immunocompromised populations.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 165 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 165 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 15%
Researcher 24 15%
Student > Ph. D. Student 22 13%
Student > Postgraduate 17 10%
Student > Bachelor 13 8%
Other 36 22%
Unknown 28 17%
Readers by discipline Count As %
Medicine and Dentistry 62 38%
Nursing and Health Professions 15 9%
Agricultural and Biological Sciences 13 8%
Social Sciences 7 4%
Biochemistry, Genetics and Molecular Biology 5 3%
Other 26 16%
Unknown 37 22%